Objective. To quantify healthcare utilization and costs by disease severity for patients with
systemic lupus erythematosus (SLE) in the United States. Methods. We conducted …

Objective To estimate the economic burden of systematic lupus erythematous (SLE),
stratified by disease severity, in commercially-and Medicaid-insured US populations …

Objective A structured review of the literature was undertaken to examine the direct costs of
adult systemic lupus erythematosus (SLE) in a US population. Methods English‐language …

Objective Our aim was to estimate annual health care resource use and medical costs
associated with systemic lupus erythematosus (SLE) in a large US managed care health …

Objective. Healthcare utilization and costs associated with systemic lupus erythematosus
(SLE) in a US Medicaid population were examined. Methods. Patients≥ 18 years old with …

Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder which
can affect multiple organs of the body, requiring ongoing disease management and …

Objective: To assess healthcare resource utilization and costs in a cohort of US managed
care patients with systemic lupus erythematosus (SLE). Methods: Claims data from a large …

Objective To evaluate the annual direct medical cost of systemic lupus erythematosus (SLE)
in Canada by disease severity and to estimate the incremental cost associated with disease …

Aims: Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease involving
multiple organs systems and places a significant economic burden on SLE patients. There is …

Objective To estimate the long‐term direct medical costs and health care utilization for
patients with systemic lupus erythematosus (SLE) and a subset of SLE patients with …